TRACON Pharmaceuticals, Inc. Gains 34.48%
Tue, Mar 12, 2024 at 07:22 PM
TRACON Pharmaceuticals, Inc. (TCON:NASDAQ) soared at $0.39, representing a gain of 34.5%. On Tue, Mar 12, 2024, TCON:NASDAQ hit a New 2-Week High of $0.39. The stock got featured on our News Catalysts scanner on Tue, Mar 05, 2024 at 06:39 PM in the 'INVESTOR UPDATE' category. From Tue, Feb 27, 2024, the stock recorded 60.00% Up Days and 45.45% Green Days
About TRACON Pharmaceuticals, Inc. (TCON:NASDAQ)
TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 494.06%
- ClearOne, Inc. (CLRO:NASDAQ), 127.5%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- HNR Acquisition Corp (HNRA:NYSEMKT), 121.21%
- Regulus Therapeutics Inc. (RGLS:NASDAQ), 71.01%
- Ranpak Holdings Corp. (PACK:NYSE), 51.72%
- Li-Cycle Holdings Corp. (LICY:NYSE), 46.32%
- Bright Green Corporation (BGXX:NASDAQ), 45.72%
- Semilux International Ltd. (SELX:NASDAQ), 38.5%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 34.48%